# Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC

> **NCT01282437** · PHASE3 · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 315 (actual)

## Conditions studied

- Non Small Cell Lung Cancer (NSCLC)
- Radical Treatment
- Stage III Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** Prophylactic Cranial Irradiation

## Key facts

- **NCT ID:** NCT01282437
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-09
- **Final completion:** 2015-03
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2015-04-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282437, "Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01282437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*